NEOMYCIN SULFATE
Generic: NEOMYCIN SULFATE
Chartwell RXManufacturer
ORALRoute
NEOMYCIN SULFATEActive Substance
2016-06-10Original Approval
NEOMYCIN SULFATE is FDA application ANDA204435, sponsored by CHARTWELL MOLECULAR. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-08-23
Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North WCGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingred
Class II2021-03-15
NEOMYCIN SULF TABLETS, USP, 500mg, 100-count bottle, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., North WaleCGMP Deviations: Intermittent exposure to temperature excursion during storage.
Top Reported Reactions
1
DRUG HYPERSENSITIVITY
519 reports
2
DRUG INEFFECTIVE
398 reports
3
PAIN
359 reports
4
OFF LABEL USE
273 reports
5
NAUSEA
270 reports
6
DYSPNOEA
265 reports
7
MALAISE
251 reports
8
INFUSION RELATED REACTION
245 reports
9
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
228 reports
10
MACULAR DEGENERATION
202 reports